Daniel L. Alkon - Net Worth and Insider Trading
Daniel L. Alkon Net Worth
The estimated net worth of Daniel L. Alkon is at least $4,053 dollars as of 2024-11-05. Daniel L. Alkon is the President and CSO of Synaptogenix Inc and owns about 1,422 shares of Synaptogenix Inc (SNPX) stock worth over $4,053. Details can be seen in Daniel L. Alkon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel L. Alkon has not made any transactions after 2022-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel L. Alkon
Daniel L. Alkon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel L. Alkon owns 2 companies in total, including Neurotrope Inc (NTRP) , and Synaptogenix Inc (SNPX) .
Click here to see the complete history of Daniel L. Alkon’s form 4 insider trades.
Insider Ownership Summary of Daniel L. Alkon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTRP | Neurotrope Inc | 2019-01-22 | See Remarks |
| SNPX | Synaptogenix Inc | 2022-12-16 | director & Chief Scientific Officer |
Daniel L. Alkon Latest Holdings Summary
Daniel L. Alkon currently owns a total of 1 stock. Daniel L. Alkon owns 1,422 shares of Synaptogenix Inc (SNPX) as of December 16, 2022, with a value of $4,053.
Latest Holdings of Daniel L. Alkon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNPX | Synaptogenix Inc | 2022-12-16 | 1,422 | 2.85 | 4,053 |
Holding Weightings of Daniel L. Alkon
Daniel L. Alkon Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel L. Alkon has made a total of 1 transactions in Synaptogenix Inc (SNPX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Synaptogenix Inc is the sale of 788 shares on December 16, 2022, which brought Daniel L. Alkon around $23,035.
Insider Trading History of Daniel L. Alkon
- 1
Daniel L. Alkon Trading Performance
Daniel L. Alkon Ownership Network
Ownership Network List of Daniel L. Alkon
Ownership Network Relation of Daniel L. Alkon
Daniel L. Alkon Owned Company Details
What does Neurotrope Inc do?
Who are the key executives at Neurotrope Inc?
Daniel L. Alkon is the See Remarks of Neurotrope Inc. Other key executives at Neurotrope Inc include director & Chief Executive Officer Charles S. Ryan , COO and General Counsel Michael Ciraolo , and See Remarks Robert Weinstein .
Neurotrope Inc (NTRP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neurotrope Inc (NTRP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurotrope Inc (NTRP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neurotrope Inc (NTRP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurotrope Inc Insider Transactions
Daniel L. Alkon Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel L. Alkon. You might contact Daniel L. Alkon via mailing address: C/o Neurotrope, Ine., 205 East 42nd Street - 20th Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
